BeOne Medicines
ONC
#533
Rank
C$64.00 B
Marketcap
C$560.32
Share price
-2.19%
Change (1 day)
12.78%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): C$11.55

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is C$11.74. In 2025 the company made an earnings per share (EPS) of C$3.91 an increase over its 2024 EPS that were of C-$8.94.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$11.55195.14%
2025C$3.91-143.75%
2024C-$8.94
2022C-$27.9528.21%
2021C-$21.80-19.96%
2020C-$27.2420.81%
2019C-$22.5531.52%
2018C-$17.14417.57%
2017C-$3.31-37.16%
2016C-$5.27158.95%
2015C-$2.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
C-$0.27-102.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C-$1.36-111.60%๐Ÿ‡บ๐Ÿ‡ธ USA